House-Dust Mite Immunotherapy in Asthma: Uncertainties and Therapeutic Strategies

被引:2
作者
Liew, Mei Fong [1 ,2 ]
Chan, Adrian [3 ]
Lim, Hui Fang [1 ,2 ]
机构
[1] Natl Univ Hlth Syst, Univ Med Cluster, Div Resp & Crit Care Med, 1E Kent Ridge Rd, Singapore 119228, Singapore
[2] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore
[3] Singapore Gen Hosp, Dept Resp & Crit Care Med, Singapore, Singapore
关键词
House dust mite sensitisation; Allergen immunotherapy; Allergy; Allergic asthma; Immunotolerance; Disease-modifying; Subcutaneous immunotherapy; Sublingual immunotherapy; ALLERGEN-SPECIFIC IMMUNOTHERAPY; IMPERMEABLE BED COVERS; IGE CROSS-REACTIVITY; BLOMIA-TROPICALIS; SUBLINGUAL IMMUNOTHERAPY; AEROALLERGEN SENSITIZATION; INTERNATIONAL CONSENSUS; RESPIRATORY ALLERGY; ATOPIC-DERMATITIS; COMMON ALLERGENS;
D O I
10.1007/s40521-019-00236-9
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of reviewThe prevalence of house dust mites (HDM)-sensitization is high in allergic asthma (AA), especially in tropical/subtropical countries in Asia and South America. As HDM-sensitization can contribute to the subsequent development of HDM-driven asthma, poor asthma control and exacerbations, allergen immunotherapy (AIT) might reduce the growing global burden of allergic asthma.Recent findingsAIT builds immunotolerance via upregulation of T-regulatory (reg) cells, leading to increase secretion of IL-10 and TGF-beta which suppress the Th2 response to allergens. IL-10 also induces the class-switch to plasma cells that produce IgG4 that competes with Ig E's binding on mast cell. Encouragingly, 2 recent multicentre trials showed that HDM AIT could lead to improvements in clinically relevant health outcomes: reduction in asthma exacerbations and inhaled corticosteroid usage.The uptake of AIT remains low due to difficulties with long-term adherence and lack of robust cost-effectiveness studies. There is limited standardization of techniques to compare the efficacy between different AIT administration routes and formulation. In clinical practice, it is challenging to differentiate "asthma with HDM sensitization" from "HDM-driven asthma". Additionally, Blomia tropicalis (Blo.t) play an important allergenic role especially in tropics, in addition to the Dermatophagoides species but is not found in many AIT formulations. It is uncertain if Blo.t sensitised patients will respond equally to these HDM AIT.SummaryWe will summarise (a) global differences in HDM sensitization, (b) disease-modifying mechanisms behind HDM AIT (c) differences between the subcutaneous and sublingual route (d) therapeutic strategies in HDM-driven asthma to maximise cost-effectiveness.
引用
收藏
页码:363 / 376
页数:14
相关论文
共 50 条
[41]   Early Intervention Improves Clinical Responses to House Dust Mite Immunotherapy in Allergic Rhinitis Patients [J].
Qi, Shanshan ;
Chen, Hao ;
Huang, Nan ;
Li, Wenjing ;
Liu, Guanghui ;
Wang, Yin ;
Hu, Lintao ;
Wang, Xiaolong ;
Zhang, Wei ;
Zhu, Rongfei .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2016, 171 (3-4) :234-240
[42]   House-dust mite sublingual-swallow immunotherapy in perennial conjunctivitis: a double-blind, placebo-controlled study [J].
Mortemousque, B ;
Bertel, F ;
De Casamayor, J ;
Verin, P ;
Colin, J .
CLINICAL AND EXPERIMENTAL ALLERGY, 2003, 33 (04) :464-469
[43]   Effects of sublingual immunotherapy in a murine asthma model sensitized by intranasal administration of house dust mite extracts [J].
Shima, Ienjiro ;
Koya, Toshiyuki ;
Tsukioka, Keisuke ;
Sakagami, Takuro ;
Hasegawa, Takashi ;
Fukano, Chiharu ;
Ohashi-Doi, Katsuyo ;
Watanabe, Satoshi ;
Suzuki, Eiichi ;
Kikuchi, Toshiaki .
ALLERGOLOGY INTERNATIONAL, 2017, 66 (01) :89-96
[44]   House Dust Mite Allergy Immunotherapy Tablet [J].
Wiwanitkit, V .
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2015, 25 (01) :83-83
[45]   Consensus on the treatment of allergic asthma with sublingual house dust mite immunotherapy in the field of pneumology [J].
Plaza, Vicente ;
Arnedillo, Aurelio ;
Blanco-Aparicio, Marina ;
Ignacio, Jose Maria ;
Urrutia, Isabel .
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (10) :1245-1249
[46]   House Dust Mite Subcutaneous Immunotherapy and Lung Function Trajectory in Children and Adolescents with Asthma [J].
Nogami, Kazutaka ;
Nagao, Mizuho ;
Takase, Takafumi ;
Yasuda, Yasuaki ;
Yamada, Shingo ;
Matsunaga, Mayumi ;
Hoshi, Miyuki ;
Hamada, Kana ;
Kuwabara, Yu ;
Tsugawa, Takeshi ;
Fujisawa, Takao .
CHILDREN-BASEL, 2022, 9 (04)
[47]   Successful treatment of atopic dermatitis with house dust mite sublingual immunotherapy tablets [J].
Kiatiwat, Ploykarn ;
Mitthamsiri, Wat ;
Boonpiyathad, Tadech ;
Pradubpongsa, Panitan ;
Sangasapaviliya, Atik .
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2024, 42 (03) :253-257
[48]   Clinical and cytokine responses to house dust mite sublingual immunotherapy [J].
Potter, Paul C. ;
Baker, Sheila ;
Fenemore, Bartha ;
Nurse, Barbara .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 114 (04) :327-334
[49]   House dust mite sublingual immunotherapy: Results of a US trial [J].
Bush, Robert K. ;
Swenson, Cheri ;
Fahlberg, Beth ;
Evans, Michael D. ;
Esch, Robert ;
Busse, William W. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (04) :974-U225
[50]   Indications for house dust mite allergen-specific immunotherapy [J].
Leung, Christy W. M. ;
Chu, H. C. ;
Leung, Jonathan C. H. ;
Leung, T. F. .
HONG KONG MEDICAL JOURNAL, 2023, 29 (05) :469-471